Presentation Information
[S-23-1]Clinical implementation of disease modifying therapies on Alzheimer's disease in Japan
Ryoko Ihara (Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan)
Dr. Ihara graduated from the University of Tokyo in 2002 and completed her neurology residency in 2007. She established memory clinics at the University of Tokyo Hospital in 2008. During her PhD, she conducted research on TDP-43 proteinopathy using a Drosophila model. After earning her PhD, she focused on clinical research and practice in Alzheimer’s disease. From 2015 to 2016, she joined the Knight ADRC at Washington University in St. Louis and contributed to the initiation of DIAN-Japan. Her main research interests include optimizing to identify individuals with preclinical Alzheimer’s disease and raising awareness of its earliest stages. Currently, she is leading efforts to integrate anti-amyloid-β antibody therapy into clinical practice in Japan, having established a specialized outpatient clinic for this purpose in 2023. She continues to balance clinical practice, research, and advocacy, striving to advance treatment for individuals affected by Alzheimer’s disease.